Sequential Radiotherapy and Immunotherapy May Improve Survival in Advanced NSCLC
A study published in JAMA Oncology analyzed real-world data from Hong Kong to determine the optimal sequencing of radiotherapy and immunotherapy for advanced NSCLC patients. The research aims to clarify whether concurrent or sequential treatment provides better survival outcomes.
Why it matters
Optimizing treatment protocols for lung cancer can significantly improve patient survival rates and quality of life.
Title: Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
The article reports on clinical research findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in